Longevity UnmaskedLongevity Unmasked

Question 300 of 433

If I decide to use peptides anyway, how do I reduce the risk?

Evidence grade (draft mapping)JClinical judgment / author synthesis
Glowing red-light panel in a dark room

The short answer

The safer choice is to avoid unproven injectables outside a legitimate study. Medical supervision can reduce some risks; it cannot make an unstudied product proven or guarantee safety.

Do not inject a product labeled for research only or not for human use. A licensed pharmacy and a prescription are necessary safeguards in appropriate circumstances, not universal proof that a particular preparation is lawful, pure, effective, or safe.

If someone proposes an experimental treatment, ask for the human evidence, regulatory basis, specific goal, known and unknown risks, follow-up plan, and how a complication will be managed. Routine blood work or cancer screening cannot clear an unknown treatment of risk.

Tell every treating clinician what you use. If you have already injected an uncertain product and develop fever, breathlessness, severe pain, rash, or other concerning symptoms, seek prompt medical assessment and bring the packaging if available.

“This book is for education. It is not medical advice, and reading it does not make you my patient or create a doctor-patient relationship.” From the book’s medical disclaimer. Full disclaimer

Evidence scope
HARM-REDUCTION JUDGMENT — Licensed sourcing and monitoring cannot establish safety or make an unlawful preparation permissible.Evidence grade (draft mapping)JClinical judgment / author synthesisPart 20, Q300 · Sources: R12

Sources cited

  • R12 US Food and Drug Administration. Pharmacy Compounding Advisory Committee meeting materials, July 23–24, 2026. Link pending verification
All of Part 20

Related questions